ATE451475T1 - Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben - Google Patents
Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-probenInfo
- Publication number
- ATE451475T1 ATE451475T1 AT04777581T AT04777581T ATE451475T1 AT E451475 T1 ATE451475 T1 AT E451475T1 AT 04777581 T AT04777581 T AT 04777581T AT 04777581 T AT04777581 T AT 04777581T AT E451475 T1 ATE451475 T1 AT E451475T1
- Authority
- AT
- Austria
- Prior art keywords
- cns
- systems
- nervous system
- central nervous
- samples
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48472603P | 2003-07-03 | 2003-07-03 | |
| US48468303P | 2003-07-03 | 2003-07-03 | |
| PCT/US2004/021543 WO2005007892A1 (en) | 2003-07-03 | 2004-07-02 | Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451475T1 true ATE451475T1 (de) | 2009-12-15 |
Family
ID=34083317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04777581T ATE451475T1 (de) | 2003-07-03 | 2004-07-02 | Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20060263783A1 (de) |
| EP (1) | EP1649062B1 (de) |
| JP (1) | JP2007531494A (de) |
| AT (1) | ATE451475T1 (de) |
| AU (1) | AU2004258101B2 (de) |
| CA (1) | CA2531281A1 (de) |
| DE (1) | DE602004024539D1 (de) |
| WO (1) | WO2005007892A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2094871A4 (de) * | 2006-11-16 | 2010-03-31 | Gentron Llc | Verfahren, systeme und zusammensetzungen zur diagnose von krebs |
| JP2010533869A (ja) | 2007-07-16 | 2010-10-28 | カリフォルニア インスティチュート オブ テクノロジー | 標的分子を検出するためのマイクロ流体装置、方法及びシステム |
| JPWO2009020058A1 (ja) | 2007-08-03 | 2010-11-04 | 学校法人慶應義塾 | 脱髄病変へのドラッグデリバリーシステム及び脱髄病変の生化学的マーカー |
| WO2009051238A1 (ja) * | 2007-10-18 | 2009-04-23 | Riken | ヒト白血病幹細胞および白血病非幹細胞が増幅されたマウスおよびその製造方法 |
| WO2010030293A1 (en) * | 2008-09-15 | 2010-03-18 | Gentron, Inc. | Methods, systems, and compositions for cancer diagnosis |
| WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
| JP2011149859A (ja) * | 2010-01-22 | 2011-08-04 | Igaku Seibutsugaku Kenkyusho:Kk | 食道癌マーカー |
| US20130151197A1 (en) * | 2011-11-23 | 2013-06-13 | General Electric Company | Automated performance measurement processes and systems |
| US8912159B2 (en) * | 2012-02-24 | 2014-12-16 | National Institutes Of Health (Nih) | Analyzing semaphorin7a (Sema7A) levels for assessing cancer metastatic potential and methods of treatment |
| CN104884605B (zh) | 2012-08-24 | 2018-05-18 | 耶鲁大学 | 用于高通量多重检测的系统、装置和方法 |
| EP3227684B1 (de) | 2014-12-03 | 2019-10-02 | Isoplexis Corporation | Analyse und screening für die sekretionprofile von zellen |
| US11353448B2 (en) | 2015-02-13 | 2022-06-07 | California Institute Of Technology | Methods and compositions for quantifying metabolites and proteins from single cells |
| EA037995B1 (ru) * | 2015-02-24 | 2021-06-21 | Рупрехт-Карлс-Университет Гейдельберг | Панель биомаркеров для обнаружения рака |
| US20200166518A1 (en) | 2016-09-12 | 2020-05-28 | IsoPlexis Corporation | System and methods for multiplexed analysis of cellular and other immunotherapeutics |
| US11493508B2 (en) | 2016-11-11 | 2022-11-08 | IsoPlexis Corporation | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells |
| US11525783B2 (en) | 2016-11-22 | 2022-12-13 | IsoPlexis Corporation | Systems, devices and methods for cell capture and methods of manufacture thereof |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| KR102207697B1 (ko) * | 2019-06-24 | 2021-01-26 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| KR20210000253A (ko) * | 2019-12-16 | 2021-01-04 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| KR102207696B1 (ko) * | 2019-06-24 | 2021-01-26 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| KR102207699B1 (ko) * | 2019-06-24 | 2021-01-26 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| KR102100588B1 (ko) * | 2019-06-24 | 2020-04-13 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| KR102207698B1 (ko) * | 2019-06-24 | 2021-01-26 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| KR20210000255A (ko) * | 2019-12-16 | 2021-01-04 | 재단법인 대구경북첨단의료산업진흥재단 | 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물 |
| CN115176158A (zh) | 2020-02-27 | 2022-10-11 | 伊索普莱克西斯公司 | 用于多路分析的系统、装置及方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995005864A1 (en) * | 1993-08-27 | 1995-03-02 | Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services | Convection-enhanced drug delivery |
| EP1132473A4 (de) * | 1998-11-20 | 2002-06-12 | Fuso Pharmaceutical Ind | Serinprotease bssp6 |
| BR0008480A (pt) * | 1999-02-23 | 2002-10-22 | Warner Lambert Co | Sistema e processo para controle e apresentação de informação derivada de determinação do perfil de expressão de gene |
| AU773329B2 (en) * | 1999-05-14 | 2004-05-20 | Proteomedica Ab | Materials and methods relating to disease diagnosis |
| EP1274861B1 (de) * | 2000-03-27 | 2009-12-23 | Thomas Jefferson University | Zusammensetzungen und methoden zur identifizierung von krebszellen |
| US6372250B1 (en) * | 2000-04-25 | 2002-04-16 | The Regents Of The University Of California | Non-invasive gene targeting to the brain |
| US7105293B2 (en) * | 2000-09-19 | 2006-09-12 | Whitehead Institute For Biomedical Research | Genetic markers for tumors |
| US20030064385A1 (en) * | 2001-05-16 | 2003-04-03 | Dressman Marlene Michelle | Genes expressed in breast cancer as prognostic and therapeutic targets |
| CN1612936A (zh) * | 2001-11-09 | 2005-05-04 | 苏尔斯精细医药公司 | 利用基因表达分布图识别、监控和治疗疾病以及鉴定生物学状态 |
-
2004
- 2004-07-02 EP EP04777581A patent/EP1649062B1/de not_active Expired - Lifetime
- 2004-07-02 US US10/563,049 patent/US20060263783A1/en not_active Abandoned
- 2004-07-02 WO PCT/US2004/021543 patent/WO2005007892A1/en not_active Ceased
- 2004-07-02 CA CA002531281A patent/CA2531281A1/en not_active Abandoned
- 2004-07-02 AT AT04777581T patent/ATE451475T1/de not_active IP Right Cessation
- 2004-07-02 DE DE602004024539T patent/DE602004024539D1/de not_active Expired - Lifetime
- 2004-07-02 JP JP2006518833A patent/JP2007531494A/ja active Pending
- 2004-07-02 AU AU2004258101A patent/AU2004258101B2/en not_active Ceased
-
2011
- 2011-02-28 US US13/036,536 patent/US20110251077A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060263783A1 (en) | 2006-11-23 |
| EP1649062A1 (de) | 2006-04-26 |
| DE602004024539D1 (de) | 2010-01-21 |
| CA2531281A1 (en) | 2005-01-27 |
| AU2004258101A1 (en) | 2005-01-27 |
| AU2004258101B2 (en) | 2010-12-23 |
| WO2005007892A1 (en) | 2005-01-27 |
| JP2007531494A (ja) | 2007-11-08 |
| US20110251077A1 (en) | 2011-10-13 |
| EP1649062B1 (de) | 2009-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004024539D1 (de) | Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben | |
| ATE440536T1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
| DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
| WO2005052592A3 (en) | Methods for diagnosis, stratification, and monitoring of alzheimer’s disease | |
| EP4257705A3 (de) | Biomarker für traumatische hirnverletzungen | |
| WO2007033216A3 (en) | Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state | |
| WO2008146309A3 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| EA200600920A1 (ru) | Иммуносорбентные исследования крови для оценки пароксизмальных церебральных разрядов | |
| NO20070949L (no) | Transkriptomdiagnostikk i spytt | |
| WO2006134390A3 (en) | Method for diagnosing neurodegenerative disease | |
| WO2007080597A3 (en) | Polynucleotide and polypeptide sequences and methods for diagnosis | |
| ATE511651T1 (de) | Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen | |
| EP2365335A3 (de) | Diagnoseverfahren | |
| WO2004045376A3 (en) | Screening methods to identify treatments for autoimmune disease | |
| WO2007032876A3 (en) | Biomarkers associated with age-related macular degeneration | |
| WO2006059252A3 (en) | Methods and fluorinated compositions for treating amyloid-related diseases | |
| WO2008008487A3 (en) | Gene expression profiling for identification, monitoring and treatment of multiple sclerosis | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
| ATE470153T1 (de) | Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie | |
| WO2006074450A3 (en) | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases | |
| WO2006121912A3 (en) | Diagnostic methods for the detection of risk of neurodevelopmental disorders | |
| WO2006002240A3 (en) | Computer systems and methods for constructing biological classifiers and uses thereof | |
| WO2007050588A3 (en) | Systems and methods for characterizing conditions of organs for transplantation | |
| WO2005093413A3 (en) | Diagnosis and treatment of preeclampsia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |